TSXV - Delayed Quote ? CAD Covalon Technologies Ltd. (COV.V) Follow Compare 3.1400 -0.0400 (-1.26%) At close: October 18 at 3:59 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting MISSISSAUGA, Ontario, September 27, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the 2024 Association for Vascular Access ("AVA") Annual Scientific Meeting. The event will take place from September 28 to 30 in Colorado. Founded in 1985, AVA’s multidisciplinary membership is dedicated to advancing research, providing education, and fostering collaboration to improve patient outcomes in vascular access. Covalon Business Wire ? 23 days ago CVALF Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver VANCOUVER, BC / ACCESSWIRE / September 24, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VANCOUVER taking place on September 25-26, 2024, where 50 MicroCap public and private companies will be presenting at the Fairmont Waterfront ... ACCESSWIRE ? 26 days ago SSLCF GHIFF NWVCF Covalon Announces Successful Warrant Redemption from 2019 Private Placement MISSISSAUGA, Ontario, September 23, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that the directors of the Company (the "Insiders") have exercised a cumulative total of 852,700 common share purchase warrants ("warrants"), generating proceeds of approximately $1.7 million CAD. In addition to the Insiders, long-term shareholders exercised 1,875,800 warrants, generating proceeds of approximat Business Wire ? 27 days ago CVALF Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST MISSISSAUGA, ON / ACCESSWIRE / September 19, 2024 / Covalon Technologies Ltd., ("Covalon"), (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting and participating in meetings at the Planet MicroCap ... ACCESSWIRE ? last month CVALF Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference MISSISSAUGA, Ontario, September 11, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Association of Pediatric Hematology/Oncology Nurses (APHON) Annual 2024 Conference. The conference, taking place in Salt Lake City, Utah from September 11 to 13, is a premier event for pediatric hematology/oncology nursing professionals involved in patient care, education, case management, an Business Wire ? last month CVALF Covalon Announces Strong Third Quarter Fiscal 2024 Results MISSISSAUGA, Ontario, August 21, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 third quarter results for the period ended June 30, 2024. Business Wire ? last month CVALF We Think Covalon Technologies (CVE:COV) Can Easily Afford To Drive Business Growth We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made... Simply Wall St. ? last month CVALF Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2024 Financial Results MISSISSAUGA, Ontario, August 14, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2024 financial results on Wednesday, August 21, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, August 21, 2024, at 8:30am ET. Business Wire ? 2 months ago CVALF Covalon Technologies Second Quarter 2024 Earnings: EPS: CA$0.06 (vs CA$0.028 loss in 2Q 2023) Covalon Technologies ( CVE:COV ) Second Quarter 2024 Results Key Financial Results Revenue: CA$8.41m (up 16% from 2Q... Simply Wall St. ? 4 months ago CVALF Covalon Announces Profitable Second Quarter Fiscal 2024 Results MISSISSAUGA, Ontario, May 29, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 second quarter results for the period ended March 31, 2024. Business Wire ? 4 months ago CVALF Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results MISSISSAUGA, Ontario, May 22, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, May 29, 2024, at 8:15am ET. Business Wire ? 4 months ago CVALF Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO MISSISSAUGA, Ontario, May 17, 2024--INS 2024 Meeting attendees are invited to explore Covalon’s innovative vascular access products first-hand. Business Wire ? 5 months ago CVALF Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders MISSISSAUGA, Ontario, March 07, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders ("AGM") held March 6, 2024. Business Wire ? 7 months ago CVALF Covalon Announces First Quarter Fiscal 2024 Results MISSISSAUGA, Ontario, February 28, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023. Business Wire ? 7 months ago CVALF Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024 MISSISSAUGA, Ontario, February 28, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 6, 2024 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s recently appointed CEO, Brent Ashton, with Business Wire ? 7 months ago CVALF Covalon Technologies Full Year 2023 Earnings: CA$0.18 loss per share (vs CA$0.36 loss in FY 2022) Covalon Technologies ( CVE:COV ) Full Year 2023 Results Key Financial Results Revenue: CA$26.6m (up 47% from FY 2022... Simply Wall St. ? 8 months ago CVALF Covalon Announces Management Changes MISSISSAUGA, Ontario, January 26, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the following management changes. Business Wire ? 8 months ago CVALF Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023 MISSISSAUGA, Ontario, January 26, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2023 fourth quarter and year end results for the period ended September 30, 2023. Business Wire ? 8 months ago CVALF Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO MISSISSAUGA, Ontario, January 04, 2024--Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF) (the "Company" or "Covalon"), an advanced medical technologies company, today announced that its Board of Directors (the "Board") has appointed Mr. Brent Ashton to serve as Chief Executive Officer and a director of the Company, effective immediately. Business Wire ? 9 months ago CVALF Covalon’s VALGuard Gains Prestigious Recognition in the British Journal of Nursing MISSISSAUGA, Ontario, November 15, 2023--British Journal of Nursing’s CE credit-eligible article on sources of CVAD contamination as a major contributor to CLABSI features Covalon’s VALGuard Business Wire ? 10 months ago CVALF Performance Overview Trailing total returns as of 10/18/2024, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index Return COV.V S&P/TSX Composite index YTD +196.23% +18.44% 1-Year +116.55% +26.05% 3-Year +14.18% +18.61%
